1. Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time
- Author
-
Matthias Schmitt, Paul Welsh, Hany Eteiba, Elisa McAlindon, Campbell Tait, Naveed Sattar, Annette Maznyczka, Neil Maredia, Alex McConnachie, Peter McCartney, Colin Berry, Aleksandra Radjenovic, Vanessa Orchard, John P Greenwood, Keith G. Oldroyd, Timothy A. Fairbairn, Ian Ford, Gerry P McCann, Thomas J. Ford, Margaret McEntegart, David Corcoran, and T-Time Investigators
- Subjects
Male ,Time Factors ,Heart disease ,medicine.medical_treatment ,microvascular obstruction ,Myocardial Ischemia ,Ischemic time ,030204 cardiovascular system & hematology ,AUC, area under the curve ,0302 clinical medicine ,CMR, cardiac magnetic resonance ,Medicine ,Thrombolytic Therapy ,030212 general & internal medicine ,Myocardial infarction ,Prospective Studies ,STEMI, ST-segment elevation myocardial infarction ,myocardial hemorrhage ,Darkness ,Middle Aged ,primary percutaneous coronary intervention ,Tissue Plasminogen Activator ,Cardiology ,MI, myocardial infarction ,fibrinolysis ,Female ,Cardiology and Cardiovascular Medicine ,medicine.medical_specialty ,MVO, microvascular obstruction ,Placebo ,TIMI, Thrombolysis In Myocardial Infarction ,Article ,Time ,PPCI, primary percutaneous coronary intervention ,03 medical and health sciences ,Percutaneous Coronary Intervention ,Double-Blind Method ,Fibrinolytic Agents ,Internal medicine ,Fibrinolysis ,Humans ,IQR, interquartile range ,Aged ,Dose-Response Relationship, Drug ,business.industry ,Percutaneous coronary intervention ,medicine.disease ,ST-segment elevation myocardial infarction ,OR, odds ratio ,Conventional PCI ,Adjunctive treatment ,ST Elevation Myocardial Infarction ,business - Abstract
Background Microvascular obstruction affects one-half of patients with ST-segment elevation myocardial infarction and confers an adverse prognosis. Objectives This study aimed to determine whether the efficacy and safety of a therapeutic strategy involving low-dose intracoronary alteplase infused early after coronary reperfusion associates with ischemic time. Methods This study was conducted in a prospective, multicenter, parallel group, 1:1:1 randomized, dose-ranging trial in patients undergoing primary percutaneous coronary intervention. Ischemic time, defined as the time from symptom onset to coronary reperfusion, was a pre-specified subgroup of interest. Between March 17, 2016, and December 21, 2017, 440 patients, presenting with ST-segment elevation myocardial infarction within 6 h of symptom onset (, Central Illustration
- Published
- 2019